Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Comparison of Visian toric collamer lens and Acrysof toric lens implantation for myopic astigmatism treatment

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Phakic IOLs III

Session Date/Time: Tuesday 13/09/2016 | 09:30-11:00

Paper Time: 10:20

Venue: Poster Village: Pod 4

First Author: : H.Ammar EGYPT

Co Author(s): :                  

Abstract Details


To compare the efficacy and outcome of phakic toric implantable collamer lens (PTICL) and refractive clear lens extraction with toric AcrySof intraocular lens implantation (TIOL) for the treatment of myopic astigmatism.


Ophthalmology department, Sohag university, Egypt


This study assessed eyes with myopic astigmatism >-1D and ≤-4D with a spherical equivalent (SE) of >10D or less than 10D if the patients were unsuitable for corneal refractive surgery. These eyes were divided into group A, in which Visian toric ICLTM PTICL was implanted and group B, which involved clear lens extraction with implantation of an Acrysof IQ toric SN60T3-9TM IOL. The outcome and complications were evaluated.


This study enrolled 63 eyes of 38 patients with a follow-up period of at least 6 months. The mean postoperative SE was -0.19±0.31D in group A and -0.21±0.28D in group B (P=0.69). The mean postoperative cylinder value was -0.46±0.53D in group A and - 0.32 ±0.41D in group B (P=0.35). Postoperative cylinder was less than 1D in 76.47% and 79.31% in groups A & B, respectively. The mean endothelial cell count reduced by 4.32% in group A and 5.32% in group B (P=0.003). The mean postoperative IOP increased insignificantly in group A (P=0.22) and reduced significantly in group B (P=0.004). Complication rate was 8.82% in group A and 6.90% in group B.


Both procedures show predictable results with slightly (but statistically insignificant) better refractive and visual results in the TIOL group, but with loss of accommodation, indicating the use of TICL for myopic astigmatism in young patients.

Financial Disclosure:


Back to previous